Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel low-temperature route avoids 180°C rearrangement. High yield 83%. Cost-effective industrial scale-up for pharmaceutical intermediates manufacturing.
Patent CN112299972B reveals a novel Grignard route for esketamine ketone body, offering superior purity and yield for reliable pharmaceutical intermediate supply chains.
Novel Grignard route for o-chlorophenyl cyclopentyl ketone. High yield, mild conditions, scalable API intermediate manufacturing for global supply chains.